Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Bang, Yung-Jue, Prof ; Van Cutsem, Eric, Prof ; Feyereislova, Andrea, MD ; Chung, Hyun C, Prof ; Shen, Lin, Prof ; Sawaki, Akira, MD ; Lordick, Florian, MD ; Ohtsu, Atsushi, MD ; Omuro, Yasushi, MD ; Satoh, Taroh, MD ; Aprile, Giuseppe, MD ; Kulikov, Evgeny, MD ; Hill, Julie, PhD ; Lehle, Michaela, PhD ; Rüschoff, Josef, Prof ; Kang, Yoon-Koo, Prof

The Lancet (British edition), 2010-08, Vol.376 (9742), p.687-697 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível